- Home
- IVT vs VCEL Comparison
IVT vs VCEL Comparison
Compare IVT & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IVT | VCEL |
|---|---|---|
| Founded | 2005 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.0B |
| IPO Year | 2005 | 1996 |
Fundamental Metrics
Financial Performance| Metric | IVT | VCEL |
|---|---|---|
| Price | $30.59 | $38.09 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 5 |
| Target Price | $32.20 | ★ $57.50 |
| AVG Volume (30 Days) | ★ 427.3K | 368.0K |
| Earning Date | 05-12-2026 | 04-03-2026 |
| Dividend Yield | ★ 3.28% | N/A |
| EPS Growth | ★ 647.37 | 385.71 |
| EPS | ★ 1.42 | N/A |
| Revenue | ★ $299,169,000.00 | $237,224,000.00 |
| Revenue This Year | $7.58 | $18.02 |
| Revenue Next Year | $4.81 | $18.52 |
| P/E Ratio | $21.47 | ★ N/A |
| Revenue Growth | 9.20 | ★ 20.10 |
| 52 Week Low | $25.21 | $29.24 |
| 52 Week High | $31.50 | $55.41 |
Technical Indicators
Market Signals| Indicator | IVT | VCEL |
|---|---|---|
| Relative Strength Index (RSI) | 61.19 | 55.76 |
| Support Level | $30.29 | $33.30 |
| Resistance Level | $31.13 | $38.38 |
| Average True Range (ATR) | 0.54 | 1.61 |
| MACD | 0.01 | 0.29 |
| Stochastic Oscillator | 60.72 | 92.13 |
Price Performance
Historical ComparisonAbout IVT InvenTrust Properties Corp.
InvenTrust Properties Corp is the United States of America based company qualified as a REIT (Real Estate Investment Trust). It is focused on owning, leasing, redeveloping, acquiring and managing a multi-tenant retail platform. The company's wholly-owned and managed retail properties include grocery-anchored community and neighborhood centers and power centers, including those classified as necessity-based. InvenTrust operates through a single segment i.e. multi-tenant retail.
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.